<DOC>
	<DOCNO>NCT00929526</DOCNO>
	<brief_summary>This extension study conduct assess efficacy GSK 580299 vaccine cervical intraepithelial neoplasia ( CIN ) lesion , cervical cancer cytological abnormality associate human papillomavirus ( HPV ) -16 and/or HPV-18 oncogenic HPV type additional two year . All subject participate primary vaccination study NCT00316693 confirm interest participate long term follow study therefore invite follow 48 month administration first dose vaccine . In addition , safety persistence humoral immune response evaluate study . This protocol post deal objective &amp; outcome measure extension phase Months 36 48 . The objective &amp; outcome measure primary phase present separate protocol posting ( NCT number = NCT00316693 ) .</brief_summary>
	<brief_title>Extension Study Efficacy GSK 580299 Vaccine Japanese Women Vaccinated Primary NCT00316693 Study</brief_title>
	<detailed_description />
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects investigator believe comply requirement protocol ; Written inform consent obtain subject prior enrolment extension study ; A subject previously vaccinate NCT00316693 study . Subjects show , last NCT00316693 study visit ( Month 24 ) willingness participate extension study . Use HPV vaccine one administer NCT00316693 study ; Use investigational nonregistered product study vaccine since last NCT00316693 study visit , plan use study period ; Concurrently participate another clinical study , time study period , subject expose investigational noninvestigational product ; Subjects diagnose high grade miss cytology Month 0 NCT00316693 study ; Pregnant females female pregnant less 3 month ago .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>HPV vaccine</keyword>
	<keyword>cervical intraepithelial neoplasia ( CIN )</keyword>
	<keyword>include new onset autoimmune disease [ NOAD ] )</keyword>
	<keyword>new onset chronic disease ( NOCD )</keyword>
	<keyword>medically significant condition ( MSC )</keyword>
</DOC>